Live Zoster Vaccination Safe in RA Prior to Tofacitinib Initiation
Herpes zoster vaccine shown to be safe in patients with rheumatoid arthritis.
Herpes zoster vaccine shown to be safe in patients with rheumatoid arthritis.
Researchers found that one-third of patients remain in remission after discontinuing tofacitinib and that low baseline RF titers predict low disease activity after tofacitinib discontinuation.
Investigators conduct a systematic review to evaluate the risks and benefits of biologics as monotherapy or in combination with methotrexate in patients with rheumatoid arthritis who have not responded to previous biologic treatment.
Twelve-month trial compared tofacitinib with adalimumab as monotherapy or in combination with methotrexate.
Results were announced from a phase 3 trials assessing safety and efficacy of tofacitinib citrate for active psoriatic arthritis